Barclays’s EUDA Health Holdings EUDA Stock Holding History

Barclays’s Portfolio EUDA Stock Details EUDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,690	Closed	-$529K	–	5093
2022 Q1	$529K	Buy	+2,690	New	+$526K	﹤0.01%	2864

Other funds holding EUDA

KIM

Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $4.33B AUM 1.35% 1-Year Est. Return

CIM

Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Barclays's EUDA Position: Q2 2022 in Review

Barclays sold out of EUDA Health Holdings (EUDA) in Q2 2022, closing a stake of 2,690 shares — an estimated $529K sold.

Barclays first reported a position in EUDA in Q1 2022 and held it in 1 quarter. The position peaked at $529K in Q1 2022. 36 funds tracked by Wall St. Rank hold EUDA as of Q2 2022.

Barclays reported no remaining EUDA Health Holdings position as of Q2 2022 after selling out during the quarter.
Barclays sold 2,690 EUDA Health Holdings shares in Q2 2022, an estimated $529K.
Barclays first reported a position in EUDA Health Holdings in Q1 2022 and held it in 1 quarter.
Barclays's EUDA Health Holdings position peaked at $529K in Q1 2022.
36 funds tracked by Wall St. Rank held EUDA Health Holdings as of Q2 2022.

Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.